Cited by 887PI3K/AKT/mTOR signaling in cancerSignaling Pathways in DiseaseAutophagy in Disease and Therapy

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells

Open access

Sabers, Candace J., Martin, Mary M., Brunn, Gregory J., Williams, Josie M., Dumont, Francis J., Wiederrecht, Gregory, Abraham, Robert T.·1995·Journal of Biological Chemistry

DOI 10.1074/jbc.270.2.815

Open this paper in CoChat — free account Open PDF

Abstract

The immunosuppressive drug, rapamycin, interferes with an undefined signaling pathway required for the progression of G1-phase T-cells into S phase. Genetic analyses in yeast indicate that binding of rapamycin to its intracellular receptor, FKBP12, generates a toxic complex that inhibits cell growth in G1 phase. These analyses implicated two related proteins, TOR1 and TOR2, as targets of the FKBP12-rapamycin complex in yeast. In this study, we have used a glutathione S-transferase (GST)-FKBP12-rapamycin affinity matrix to isolate putative mammalian targets of rapamycin (mTOR) from tissue extracts. In the presence of rapamycin, immobilized GST-FKBP12 specifically precipitates similar high molecular mass proteins from both rat brain and murine T-lymphoma cell extracts. Binding experiments performed with rapamycin-sensitive and -resistant mutant clones derived from the YAC-1 T-lymphoma cell line demonstrate that the GST-FKBP12-rapamycin complex recovers significantly lower amounts of the candidate mTOR from rapamycin-resistant cell lines. The latter results suggest that mTOR is a relevant target of rapamycin in these cells. Finally, we report the isolation of a full-length mTOR cDNA that encodes a direct ligand for the FKBP12-rapamycin complex. The deduced amino acid sequence of mTOR displays 42 and 45% identity to those of yeast TOR1 and TOR2, respectively. These results strongly suggest that the FKBP12-rapamycin complex interacts with homologous ligands in yeast and mammalian cells and that the loss of mTOR function is directly related to the inhibitory effect of rapamycin on G1- to S-phase progression in T-lymphocytes and other sensitive cell types.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1074/jbc.270.2.815

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P. E., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs
Kozak, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.20.8125 · Cited by 5,090
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,010
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
Clipstone, N. A., & Crabtree, G. R. (1992) · Nature · doi:10.1038/357695a0 · Cited by 1,635
RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis
Rosenfeld, J., Capdevielle, J., Guillemot, J. C., & Ferrara, P. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90061-b · Cited by 1,239
Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases
Chung, J., Kuo, C. J., Crabtree, G. R., & Blenis, J. (1992) · Cell · doi:10.1016/0092-8674(92)90643-q · Cited by 1,151

Flagged first, then by citations

Show all 29 references

Research works printed but not linked: 1

Cafferkey, 1993, Mol. Cell. Biol., 13, 6012, 10.1128/MCB.13.10.6012 · DOI

Sorted by citations

Items 101–200 of 885

Identification of Direct Protein Targets of Small Molecules
Lomenick, B., Olsen, R. W., & Huang, J. (2010) · ACS Chemical Biology · doi:10.1021/cb100294v · Cited by 305
Foundations in Cancer Research p53 and ATM: Cell Cycle, Cell Death, and Cancer
Morgan, S. E., & Kastan, M. B. (1997) · Advances in cancer research · doi:10.1016/s0065-230x(08)60095-0 · Cited by 301
Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase
Avruch, J., Hara, K., Lin, Y., Liu, M., Long, X., Ortiz-Vega, S., & Yonezawa, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209882 · Cited by 301
Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis
Cerboni, C., Zingoni, A., Cippitelli, M., Piccoli, M., Frati, L., & Santoni, A. (2007) · Blood · doi:10.1182/blood-2006-10-052720 · Cited by 296
Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus
MacDonald, A. S., Scarola, J. A., Burke, J. T., & Zimmerman, J. J. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)89027-x · Cited by 297
The 70 kDa S6 Kinase Complexes with and Is Activated by the Rho Family G Proteins Cdc42 and Rac1
Chou, M. M., & Blenis, J. (1996) · Cell · doi:10.1016/s0092-8674(00)81257-x · Cited by 292
Metformin as an Anticancer Agent
Vancura, A., Bu, P., Bhagwat, M., Zeng, J., & Vancurova, I. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.07.006 · Cited by 274
Control of Ser2448 Phosphorylation in the Mammalian Target of Rapamycin by Insulin and Skeletal Muscle Load
Reynolds, T., Bodine, S. C., & Lawrence, J. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201142200 · Cited by 268
The Role of mTOR Signaling as a Therapeutic Target in Cancer
Popova, N. V., & Jücker, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041743 · Cited by 273
Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis
Huang, S., & Zhou, H. (2011) · Current Protein and Peptide Science · doi:10.2174/138920311795659407 · Cited by 270
Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson’s Disease
Zhu, Z., Yang, C., Iyaswamy, A., Krishnamoorthi, S., Sreenivasmurthy, S. G., Liu, J., Wang, Z., Tong, B. C., Song, J., Lu, J., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030728 · Cited by 268
Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy.
Geoerger, B., Kerr, K., Tang, C. B., Fung, K., Powell, B., Sutton, L. N., Phillips∥, P. C., & Janss, A. J. (2001) · PubMed · Cited by 261
mTOR signaling in skeletal development and disease
Chen, J., & Long, F. (2018) · Bone Research · doi:10.1038/s41413-017-0004-5 · Cited by 262
Industrial natural product chemistry for drug discovery and development
Bauer, A., & Brönstrup, M. (2013) · Natural Product Reports · doi:10.1039/c3np70058e · Cited by 262
Molecular mechanisms for the control of translation by insulin
Proud, C. G., & DENTON, M. R. (1997) · Biochemical Journal · doi:10.1042/bj3280329 · Cited by 257
Activation of Phosphatidylinositol 3-Kinase Is Sufficient for Cell Cycle Entry and Promotes Cellular Changes Characteristic of Oncogenic Transformation
Klippel, A., Escobedo, M.-A., Wachowicz, M. S., Apell, G., Brown, T. W., Giedlin, M. A., Kavanaugh, W. M., & Williams, L. T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5699 · Cited by 255
Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes
Sinars, C. R., Cheung-Flynn, J., Rimerman, R. A., Scammell, J. G., Smith, D. F., & Clardy, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0231020100 · Cited by 254
Rapamycin: an anti-cancer immunosuppressant?
Law, B. K. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.09.009 · Cited by 252
Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex
Sarbassov, D. D., & Sabatini, D. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506096200 · Cited by 248
Newer Immunosuppressive Drugs
Gummert, J. F., Ikonen, T. S., & Morris, R. E. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1061366 · Cited by 245
The Mammalian Target of Rapamycin Signaling Pathway: Twists and Turns in the Road to Cancer Therapy
Abraham, R. T., & Gibbons, J. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2798 · Cited by 244
Self-citation
Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck
Amornphimoltham, P., Patel, V., Sodhi, A., Nikitakis, N. G., Sauk, J. J., Sausville, E. A., Molinolo, A. A., & Gutkind, J. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0921 · Cited by 238
The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling
Chou, M. M., & Blenis, J. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80064-6 · Cited by 237
Control of PHAS-I by Insulin in 3T3-L1 Adipocytes
Lin, T.-A., Kong, X., Saltiel, A. R., Blackshear, P. J., & Lawrence, J. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18531 · Cited by 237
TOR Mutations Confer Rapamycin Resistance by Preventing Interaction with FKBP12-Rapamycin
Lorenz, M. C., & Heitman, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27531 · Cited by 236
4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase.
von Manteuffel, S. R., Gingras, A., Ming, X., Sonenberg, N., & Thomas, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4076 · Cited by 235
mTOR SignalingPreprint
Laplante, M., & Sabatini, D. M. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011593 · Cited by 235
TOR Signaling
Harris, T. E., & Lawrence, J. C. (2003) · Science s STKE · doi:10.1126/stke.2122003re15 · Cited by 239
Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition.
Dudkin, L., Dilling, M. B., Cheshire, P. J., Harwood, F. C., Hollingshead, M. G., Arbuck, S. G., Travis, R., Sausville, E. A., & Houghton, P. J. (2001) · PubMed · Cited by 232
mTOR: a protein kinase switching between life and death
Asnaghi, L., Bruno, P., Priulla, M., & Nicolin, A. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2004.03.007 · Cited by 236
The Insulin-Induced Signalling Pathway Leading to S6 and Initiation Factor 4E Binding Protein 1 Phosphorylation Bifurcates at a Rapamycin-Sensitive Point Immediately Upstream of p70 s6k
von Manteuffel, S. R., Dennis, P. B., Pullen, N., Gingras, A., Sonenberg, N., & Thomas, G. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5426 · Cited by 231
Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells.
Yeh, W., Bierer, B. E., & McKnight, S. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11086 · Cited by 226
Human Cytomegalovirus Up-Regulates the Phosphatidylinositol 3-Kinase (PI3-K) Pathway: Inhibition of PI3-K Activity Inhibits Viral Replication and Virus-Induced Signaling
Johnson, R. A., Wang, X., Ma, X., Huong, S., & Huang, E. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6022-6032.2001 · Cited by 228
Regulation of peptide bond cis/trans isomerization by enzyme catalysis and its implication in physiological processes
Fischer, G. S., & Aumüller, T. (2003) · Springer eBooks · doi:10.1007/s10254-003-0011-3 · Cited by 225
Immunophilins and Parvulins. Superfamily of Peptidyl Prolyl Isomerases in Arabidopsis
He, Z., Li, L., & Luan, S. (2004) · PLANT PHYSIOLOGY · doi:10.1104/pp.103.031005 · Cited by 214
Research progress of mTOR inhibitors
Chen, Y., & Zhou, X. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112820 · Cited by 219
Mammalian Target of Rapamycin: Discovery of Rapamycin Reveals a Signaling Pathway Important for Normal and Cancer Cell Growth
Gibbons, J. J., Abraham, R. T., & Yu, K. (2009) · Seminars in Oncology · doi:10.1053/j.seminoncol.2009.10.011 · Cited by 212
Self-citation
The Translational Regulation in mTOR Pathway
Yang, M., Lu, Y., Piao, W., & Jin, H. (2022) · Biomolecules · doi:10.3390/biom12060802 · Cited by 217
Mammalian target of rapamycin inhibition as therapy for hematologic malignancies
Panwalkar, A. W., Verstovšek, S., & Giles, F. J. (2004) · Cancer · doi:10.1002/cncr.20026 · Cited by 206
Proximity-Based Modalities for Biology and Medicine
Liu, X., & Ciulli, A. (2023) · ACS Central Science · doi:10.1021/acscentsci.3c00395 · Cited by 206
Accelerated wound healing by mTOR activation in genetically defined mouse models
Squarize, C. H., Castilho, R. M., Bugge, T. H., & Gutkind, J. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010643 · Cited by 203
SIROLIMUS: A POTENT NEW IMMUNOSUPPRESSANT FOR LIVER TRANSPLANTATION
Watson, C. J. E., Friend, P. J., Jamieson, N. V., Frick, T. W., Alexander, G., Gimson, A. E., & Calne, R. (1999) · Transplantation · doi:10.1097/00007890-199902270-00002 · Cited by 201
Chasing molecular glue degraders: screening approaches
Domostegui, A., Nieto-Barrado, L., Perez-Lopez, C., & Mayor-Ruiz, C. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00197g · Cited by 200
Unifying principles of bifunctional, proximity-inducing small molecules
Gerry, C. J., & Schreiber, S. L. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0469-1 · Cited by 199
Coordinate regulation of translation by the PI 3-kinase and mTOR pathways
Martin, K. A., & Blenis, J. (2002) · Advances in cancer research · doi:10.1016/s0065-230x(02)86001-8 · Cited by 204
Cytoplasmic–nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation
Kim, J. E., & Chen, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011511898 · Cited by 198
Neural actions of immunophilin ligands
Snyder, S. H., Sabatini, D. M., Lai, M. M.-S., Steiner, J. P., Hamilton, G. S., & Suzdak, P. D. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01146-2 · Cited by 198
Phospholipase D confers rapamycin resistance in human breast cancer cells
Chen, Y., Yang, Z., & Foster, D. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206565 · Cited by 197
The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor
Sodhi, A., Chaisuparat, R., Hu, J., Ramsdell, A. K., Manning, B. D., Sausville, E. A., Sawai, E. T., Molinolo, A., Gutkind, J. S., & Montaner, S. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.026 · Cited by 195
Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling
Abraham, R. T. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80172-6 · Cited by 192
Self-citation
Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide
Brazelton, T. R., & Morris, R. E. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80090-2 · Cited by 192
mTOR signaling in stem and progenitor cells
Meng, D., Frank, A. R., & Jewell, J. L. (2018) · Development · doi:10.1242/dev.152595 · Cited by 201
mTOR inhibitors: An overview
Neuhaus, P., Klupp, J., & Langrehr, J. M. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.24645 · Cited by 191
Identification of Phosphorylation Sites in the Translational Regulator, PHAS-I, That Are Controlled by Insulin and Rapamycin in Rat Adipocytes
Fadden, P., Haystead, T., & Lawrence, J. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.10240 · Cited by 191
A Novel FK506 Binding Protein Can Mediate the Immunosuppressive Effects of FK506 and Is Associated with the Cardiac Ryanodine Receptor
Lam, E., Martin, M. M., Timerman, A. P., Sabers, C. J., Fleischer, S., Lukas, T. J., Abraham, R. T., O’Keefe, S. J., O’Neill, E. A., & Wiederrecht, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26511 · Cited by 186
Self-citation
mTOR Signaling in Epilepsy: Insights from Malformations of Cortical DevelopmentPreprint
Crino, P. B. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022442 · Cited by 188
Regulation of Proline-rich Akt Substrate of 40 kDa (PRAS40) Function by Mammalian Target of Rapamycin Complex 1 (mTORC1)-mediated Phosphorylation
Wang, L., Harris, T. E., & Lawrence, J. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800723200 · Cited by 183
Lysosome: The metabolic signaling hub
Lamming, D. W., & Bar‐Peled, L. (2019) · Traffic · doi:10.1111/tra.12617 · Cited by 173
Regulation of Autophagy by Kinases
Sridharan, S., Jain, K., & Basu, A. (2011) · Cancers · doi:10.3390/cancers3022630 · Cited by 189
Interaction of RAFT1 with Gephyrin Required for Rapamycin-Sensitive Signaling
Sabatini, D. M., Barrow, R. K., Blackshaw, S., Burnett, P. E., Lai, M. M.-S., Field, M. E., Bahr, B. A., Kirsch, J., Betz, H., & Snyder, S. H. (1999) · Science · doi:10.1126/science.284.5417.1161 · Cited by 182
The Biology Behind mTOR Inhibition in Sarcoma
Wan, X., & Helman, L. J. (2007) · The Oncologist · doi:10.1634/theoncologist.12-8-1007 · Cited by 181
Immunophilins in the Nervous System
Snyder, S. H., Lai, M. M.-S., & Burnett, P. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80538-3 · Cited by 181
Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass
Goodman, C. A., Mayhew, D. L., & Hornberger, T. A. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.07.013 · Cited by 183
Autophagy Activation and Protection From Mitochondrial Dysfunction in Human Chondrocytes
de Figueroa, P. L., Lotz, M., Blanco, F. J., & Caramés, B. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39025 · Cited by 179
Pharmacodynamic Evaluation of CCI-779, an Inhibitor of mTOR, in Cancer Patients.
Peralba, J. M., deGraffenried, L. A., Friedrichs, W. E., Fulcher, L. C., Grünwald, V., Weiss, G. R., & Hidalgo, M. M. (2003) · PubMed · Cited by 175
IGF-I stimulation of proteoglycan synthesis by chondrocytes requires activation of the PI 3-kinase pathway but not ERK MAPK
Starkman, B. G., Cravero, J. D., Carlo, M. D., & Loeser, R. F. (2005) · Biochemical Journal · doi:10.1042/bj20041636 · Cited by 178
Microbial Peptidyl-Prolyl cis / trans Isomerases (PPIases): Virulence Factors and Potential Alternative Drug Targets
Ünal, C., & Steinert, M. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00015-14 · Cited by 174
Sea urchin genes expressed in activated coelomocytes are identified by expressed sequence tags. Complement homologues and other putative immune response genes suggest immune system homology within the deuterostomes
Smith, L. C., Chang, L., Britten, R. J., & Davidson, E. H. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.2.593 · Cited by 174
Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer
Albert, J. M., Kim, K. W., Cao, C., & Lu, J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0400 · Cited by 173
TOR2 Is Part of Two Related Signaling Pathways Coordinating Cell Growth in Saccharomyces cerevisiae
Helliwell, S. B., Howald, I., Barbet, N., & Hall, M. N. (1998) · Genetics · doi:10.1093/genetics/148.1.99 · Cited by 171
Haven't got a glue: Protein surface variation for the design of molecular glue degraders
Kozicka, Z., & Thomä, N. H. (2021) · Cell Chemical Biology · doi:10.1016/j.chembiol.2021.04.009 · Cited by 170
Tuberous Sclerosis Complex
DiMario, F. J., Şahin, M., & Ebrahimi‐Fakhari, D. (2015) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2015.03.005 · Cited by 169
mTORC1 signaling in hepatic lipid metabolism
Han, J., & Wang, Y. (2017) · Protein & Cell · doi:10.1007/s13238-017-0409-3 · Cited by 172
Rapamycin Antifungal Action Is Mediated via Conserved Complexes with FKBP12 and TOR Kinase Homologs in Cryptococcus neoformans
Cruz, M. C., Cavallo, L. M., Görlach, J. M., Cox, G. M., Perfect, J. R., Cardenas, M. E., & Heitman, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4101 · Cited by 168
mTOR signaling in tumorigenesis
Xu, K. L., Liu, P., & Wei, W. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.007 · Cited by 167
Rapamycin Inhibits α 1 -Adrenergic Receptor–Stimulated Cardiac Myocyte Hypertrophy but Not Activation of Hypertrophy-Associated Genes
Boluyt, M. O., Zheng, J.-S., Younès, A., Long, X., O’Neill, L., Silverman, H. S., Lakatta, E. G., & Crow, M. T. (1997) · Circulation Research · doi:10.1161/01.res.81.2.176 · Cited by 167
The Mammalian Target of Rapamycin Phosphorylates Sites Having a (Ser/Thr)-Pro Motif and Is Activated by Antibodies to a Region near Its COOH Terminus
Brunn, G. J., Fadden, P., Haystead, T., & Lawrence, J. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32547 · Cited by 167
Self-citation
The Secondary Leukemias: Challenges and Research Directions
Smith, M. A., McCaffrey, R. P., & Karp, J. E. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.7.407 · Cited by 166
Mechanism of action of rapamycin: New insights into the regulation of G1-phase progression in eukaryotic cells
Wiederrecht, G., Sabers, C. J., Brunn, G. J., Martin, M. M., Dumont, F. J., & Abraham, R. T. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1809-9_5 · Cited by 164
Self-citation
The central moTOR of metabolism
Simcox, J., & Lamming, D. W. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.02.024 · Cited by 174
Control of p70 ribosomal protein S6 kinase and acetyl‐CoA carboxylase by AMP‐activated protein kinase and protein phosphatases in isolated hepatocytes
Krause, U., Bertrand, L., & Hue, L. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03074.x · Cited by 162
Characterization of S6K2, a novel kinase homologous to S6K1
Lee-Fruman, K. K., Kuo, C. J., Lippincott, J., Terada, N., & Blenis, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202894 · Cited by 162
Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells.
Edinger, A. L., Linardic, C. M., Chiang, G. G., Thompson, C. B., & Abraham, R. T. (2003) · PubMed · Cited by 162
Self-citation
Fragments of ATM Which Have Dominant-Negative or Complementing Activity
Morgan, S. E., Lovly, C. M., Pandita, T. K., Shiloh, Y., & Kastan, M. B. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2020 · Cited by 161
Activation of pp70/85 S6 Kinases in Interleukin-2-Responsive Lymphoid Cells Is Mediated by Phosphatidylinositol 3-Kinase and Inhibited by Cyclic AMP
Monfar, M., Lemon, K. P., Grammer, T. C., Cheatham, L. A., Chung, J., Vlahos, C. J., & Blenis, J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.326 · Cited by 161
The role of mTOR in the management of solid tumors: An overview
Strimpakos, A. S., Karapanagiotou, E. M., Saif, M. W., & Syrigos, K. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.09.006 · Cited by 163
Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family
Hoekstra, M. F. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80125-6 · Cited by 160
Dual inhibition of phosphatidylinositol 3‐kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin
Khan, N., Afaq, F., Khusro, F. H., Adhami, V. M., Suh, Y. K., & Mukhtar, H. (2011) · International Journal of Cancer · doi:10.1002/ijc.26178 · Cited by 158
Signaling Pathways through Which Insulin Regulates CCAAT/Enhancer Binding Protein α (C/EBPα) Phosphorylation and Gene Expression in 3T3-L1 Adipocytes
Hemati, N., Ross, S. E., Erickson, R. L., Groblewski, G. E., & MacDougald, O. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25913 · Cited by 158
Prolonged tau clearance and stress vulnerability rescue by pharmacological activation of autophagy in tauopathy neurons
Silva, M. C., Nandi, G. A., Tentarelli, S., Gurrell, I. K., Jamier, T., Lucente, D., Dickerson, B. C., Brown, D. G., Brandon, N. J., & Haggarty, S. J. (2020) · Nature Communications · doi:10.1038/s41467-020-16984-1 · Cited by 157
Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis
Kobayashi, S., Kishimoto, T., Kamata, S., Otsuka, M., Miyazaki, M., & Ishikura, H. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00439.x · Cited by 157
Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages
Woltman, A. M., de Fijter, J. W., Kamerling, S. W. A., van der Kooij, S. W., Paul, L., Daha, M. R., & van Kooten, C. (2001) · Blood · doi:10.1182/blood.v98.1.174 · Cited by 156
The FKBP12-Rapamycin-binding Domain Is Required for FKBP12-Rapamycin-associated Protein Kinase Activity and G1 Progression
Vilella-Bach, M., Nuzzi, P., Fang, Y., & Chen, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.4266 · Cited by 154
Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone
Strömberg, T., Dimberg, A., Hammarberg, A., Carlson, K. E., Österborg, A., Nilsson, K., & Jernberg‐Wiklund, H. (2003) · Blood · doi:10.1182/blood-2003-05-1543 · Cited by 154
The evolution of the TOR pathway and its role in cancer
Beauchamp, E. M., & Platanias, L. C. (2012) · Oncogene · doi:10.1038/onc.2012.567 · Cited by 158
mTOR regulates cell survival after etoposide treatment in primary AML cells
Xu, Q., Thompson, J. E., & Carroll, M. P. (2005) · Blood · doi:10.1182/blood-2004-11-4468 · Cited by 153
Rapamycin Activates Autophagy and Improves Myelination in Explant Cultures from Neuropathic Mice
Rangaraju, S., Verrier, J. D., Madorsky, I., Nicks, J., Dunn, W. A., & Notterpek, L. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1356-10.2010 · Cited by 153
Regulation of Both Glycogen Synthase and PHAS-I by Insulin in Rat Skeletal Muscle Involves Mitogen-activated Protein Kinase-independent and Rapamycin-sensitive Pathways
Azpiazu, I., Saltiel, A. R., DePaoli-Roach, A. A., & Lawrence, J. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.5033 · Cited by 152
Programmed Cell Death Pathways and Current Antitumor Targets
Tan, M., Ooi, J. P., Ismail, N. I., Moad, A. I. H., & Muhammad, T. S. T. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9895-1 · Cited by 156
mTOR function and therapeutic targeting in breast cancer.
Hare, S. H., & Harvey, A. (2017) · PubMed Central · Cited by 150

Authors: Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., & Abraham, R. T.
Affiliations: Mayo Clinic (US)
Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Corresponding author: Abraham, Robert T.
ORCID: Abraham, Robert T.
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 1995-01
Volume: 270
Issue: 2
Pages: 815-822
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.270.2.815
OpenAlex: W2158612356
Cited by: 887
References: 29
Citations by year: 2026: 10 · 2025: 20 · 2024: 28 · 2023: 37 · 2022: 38 · 2021: 37 · 2020: 39 · 2019: 31 · 2018: 25 · 2017: 38 · 2016: 25 · 2015: 31 · 2014: 26 · 2013: 31 · 2012: 29
FWCI: 9.91
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 9442 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: Mayo Foundation for Medical Education and Research
National Institutes of Health
National Institute of General Medical Sciences (R01GM047286, GM47286)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords: rapamycin, FKBP12, mTOR, TOR1, TOR2, G1/S transition, T cells, immunosuppressants, rapamycin resistance, YAC-1 cells, cDNA cloning
MeSH terms: Amino Acid Sequence, Animals, Base Sequence, Carrier Proteins, DNA-Binding Proteins, Fungal Proteins, Heat-Shock Proteins, Humans, Molecular Sequence Data, Polyenes, Protein Kinases, Tumor Cells, Cultured, Lymphoma, T-Cell, Rats, Sprague-Dawley, Sequence Homology, Amino Acid, Phosphotransferases (Alcohol Group Acceptor), DNA Primers, DNA, Complementary, Cell Cycle Proteins, Phosphatidylinositol 3-Kinases, Sirolimus, Tacrolimus Binding Proteins, Saccharomyces cerevisiae Proteins, Rats, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks